Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice

Endocrinology

Volumn 141, Issue 4, 2000, Pages 1493-1499

  Van Buul Offers, S C ^a   Van Kleffens, M ^a   Koster, J G ^a   Lindenbergh Kortleve, D J ^a   Gresnigt, M G ^a   Drop, S L S ^a   Hoogerbrugge, C M ^a   Bloemen, R J ^a   Koedam, J A ^a   Van Neck, J W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MIXTURE; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 17744365384     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.4.7418     Document Type: Article

References (47)

1. Physiological role of the insulin-like growth factor binding proteins
2. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action
3. Insulin-like growth factor binding proteins and their role in controlling IGF actions
4. Insulin-like growth factor-binding protein proteolysis. An emerging paradigm in insulin-like growth factor physiology
5. Insulin-like growth factor binding protein-1: Recent findings and new directions
6. Double-blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency
7. Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes
8. Effects of renal failure on the growth hormone insulin-like growth factor axis
9. Phosphorylation of insulin-like growth factor binding proteins
10. Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and severe trauma
11. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I
12. Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro
13. Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats
14. Insulin-like growth factor binding protein-1 modulates blood glucose levels
15. Role of insulin-like growth factors in the endocrine control of glucose homeostasis
16. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice
17. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
18. Human insulin-like growth factor binding protein-1 (hIGFBP-1) in transgenic mice: Characterization and insights into the regulation of IGFBP-1 expression
19. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1
20. Coadministration of insulin-like growth factor (IGF)-I and IGF- binding protein-1 stimulates wound healing in animal models
21. Short stature associated with high circulating insulin-like growth factor (IGF) binding protein-1 and low circulating IGF-II: Effect of growth hormone therapy
22. Insulin-like growth factor I and II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy
23. Biosynthetic somatomedin-C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice
24. The Snell-dwarf mouse I. General growth pattern, before and during growth hormone and thyroxine therapy
25. Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3
26. Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice
27. Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice
28. A longitudinal study of the growth of the blackhooded rat: Methods of measurement and rates of growth for skull, limbs, pelvis, nose-rump and tail lengths
29. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice
30. Localization of the epitope of a monoclonal antibody against human insulin-like growth factor binding protein-1, functionally interfering with insulin-like growth factor binding
31. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
32. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
33. The S-method of multiple comparison, general case
34. Coadministration of IGF-binding proteins-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice
35. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay
36. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice
37. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone
38. Regulation and function of insulin-like growth factor binding protein-1
39. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice
40. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds
41. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1 IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy
42. rhIGF-I/IGFBP-3 (SomatoKine) therapy for the treatment of osteoporosis
43. Recombinant human insulin-like growth factor binding protein-3 (rhIG-FBP-3): Effects on the glycemic and growth promoting activities of rhIGF-I in the rat
44. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice
45. Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats
46. Insulin-like growth factor binding protein-1 induces insulin release in the rat
47. The IGF system during fetal-placental development of the mouse